Executive Director
Passage Bio
Philadelphia, Pennsylvania
Dr. Yan Ni is an Executive Director of Biomarkers and Precision Medicine at Passage Bio. The Biomarkers and Precision Medicine team is responsible for the overall biomarker strategic planning and execution for all clinical and preclinical programs in the Passage Bio drug development portfolio. Before Passage Bio, Yan was an Associate Director at the Precision Medicine Group of Regeneron Pharmaceuticals and was responsible for clinical biomarker planning and implementation for multiple disease areas from First-in-human to phase III. Yan also worked in the BioAnalytical Sciences Department at Bristol-Myers Squibb for five years, where her team provided biomarker assay development, validation, and outsourcing support for the clinical pipeline. Her industry career started at Merck Research Laboratories at Rahway, New Jersey.
Yan actively volunteers for the American Association of Pharmaceutical Scientists (AAPS) and is a co-founding member of the AAPS Biomarkers and Precision Medicine Community and the Gene and Cell Therapeutic Product Communities. She is an inventor of several patents and is recognized for her expertise in clinical biomarker development and translational science. Yan receives her PhD in Neuroscience from University of California, Irvine, and holds a Master of Science degree from the Institute of Basic Medical Sciences in Beijing.
Disclosure information not submitted.
Hot Topic: Biomarkers and Accelerated Approval for Advanced Therapy
Tuesday, May 14, 2024
2:30 PM – 3:30 PM PT
AAPS Gene and Cell Therapy Products Community Membership Meeting
Wednesday, May 15, 2024
4:00 PM – 5:00 PM PT